Hainan Shuangcheng Pharmaceuticals Co., Ltd. elected Bai Jing as non-independent director of the company, at its first extraordinary general meeting of 2022 held on 26 January 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 CNY | -4.40% |
|
-8.22% | -45.01% |
May. 22 | Workshop of Shuangcheng Pharma's Unit Passes Regulatory Inspection; Shares Up 3% | MT |
May. 07 | Shuangcheng Pharma Gets FDA Nod to Market Acromegaly Drug in US | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.01% | 237M | |
+25.59% | 45.93B | |
+36.11% | 23.66B | |
+29.93% | 16.25B | |
+20.84% | 14.63B | |
+68.80% | 14.22B | |
-0.05% | 6.79B | |
-11.31% | 6.3B | |
+15.48% | 5.77B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 002693 Stock
- News Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Hainan Shuangcheng Pharmaceuticals Co., Ltd. Elects Bai Jing as Non-Independent Director